Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

A20 protein found to be key mediator of inflammatory processes

Oct. 11, 2000

Preclinical data support clinical trials of repifermin in ulcerative colitis

Oct. 10, 2000

NitroMed's newest NO- and/or NO2-containing proton pump inhibitors

Oct. 9, 2000

Ribozyme repurchases rights to Heptazyme; phase II trial to begin

Oct. 9, 2000

BioChem Pharma reveals novel compounds for hepatitis C virus

Oct. 6, 2000

Final analysis of ISIS-2302 sparks reinitiation of development

Oct. 5, 2000

Ribozyme presents HBV data, announces formal HBV development program

Oct. 4, 2000

Anti-H. pylori agents prepared and tested at Welfide

Oct. 3, 2000

Efficacy in experimental IBD demonstrated for immunosteroid recently acquired by Hollis-Eden

Oct. 2, 2000

FDA approves Visicol

Sep. 29, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...